期刊文献+

天然产物查尔酮Sanjuanolide的首次合成 被引量:1

Total Synthesis of Natural Chalcone Sanjuanolide
下载PDF
导出
摘要 2′,4′-二羟基-3″-(2″-羟基-3″-甲基-3″-丁烯基)查尔酮Sanjuanolide是从Dalea frutescens(当地人称为达列亚草原草)中提取出来的,该天然产物对前列腺癌细胞具有明显的抗增殖活性。以廉价的2,4-二羟基苯乙酮、苯甲醛等为原料,以总收率4.8%完成了Sanjuanolide的首次全合成,并经过路线优化将总收率提高至15.3%,有效提高了合成效率,可用于Sanjuanolide的较大量合成。合成过程中的关键步骤是利用光氧化法将取代的异戊烯基侧链变成2″-羟基-3″-甲基-3″-丁烯基侧链。所有新化合物的结构都经NMR、HR-MS、IR确认。 2′,4′-Dihydroxy-3′-( 2″-methyl-3″-hydroxy-1″-butanyl) chalcone sanjuanolide was isolated from Dalea frutescens. The compound has obvious antiproliferative activity to prostate cancer cells. Chalcone sanjuanolide was first total synthesized from cheap starting material 2,4-didroxyacetophenone and benzaldehyde and the total yield was 4. 8%. Then the total yield was increased to 15. 3% by route optimization.Greatly improved the efficiency of synthesis.The key step of synthesis is to change the side chain of isopentenyl to 2″-methyl-3″-hydroxy-1″-butanyl by photo oxidation.The structures of all new compounds were confirmed by NMR,IR and HR-MS.
作者 李方辉 杨金会 牛明杰 马涛 冯月基 严志明 LI Fang-hui;YANG Jin-hui;NIU Ming-jie;MA Tao;FENG Yue-ji;YAN Zhi-ming(College of Chemistry and Chemical Engineering,State Key Laboratory of High-efficiency Utilization of Coal and Green Chemical Engineering,Ningxia University,Yinchuan 750021,China)
出处 《化学试剂》 CAS 北大核心 2018年第8期789-793,800,共6页 Chemical Reagents
基金 国家自然科学基金资助项目(21362025)
关键词 光氧化 查尔酮 全合成 抗癌 photo oxidation chalcone total synthetic antibacteria
  • 相关文献

参考文献9

二级参考文献84

  • 1谢志翔,胡杨,李瀛.First Asymmetric Synthesis of (-)Methyl 2, 2-dimethyl-3-hydroxychromanyl-6-formate[J].Journal of Chinese Pharmaceutical Sciences,2004,13(2):115-118. 被引量:2
  • 2张彦文.查尔酮类化合物的药理作用和构效关系[J].国外医学(药学分册),1996,23(4):218-223. 被引量:49
  • 3Venkateswarlu S, Panchagnula G K, Guraiah M B, et al. Isoaurostatin: total synthesis and structural revision [J]. Tertahedron, 2005, 61(12): 3013-3017.
  • 4李祎亮,石玉,刘巍,等.2,4-二羟基查尔酮类衍生物、其制备方法和用途:中国,101591230[P].2008-05-27.
  • 5Ivanova Y, Momekov G, Petrov O, et al. Cytotoxic Mannich bases of 6-(3-aryl-2-propenoyl)- 2 (3H)-benzoxazolones [J]. Eur J Med Chem, 2007, 42(11/12) :1382-1387.
  • 6Salvatore, M. J.; King, A. B.; Graham, A. C.; Onishi, H. R.; Bartizal, K. F.; Abruzzo, G. K.; Gill, C. J.; Ramjit, H. G.; Pitzenberger, S. M.; Witherup, K. M. J. Nat. Prod. 1998, 61 640.
  • 76Rahman, M. M.; Gray, A. I.; Khondkar, P.; Sarker, S. D. Pharm. Biol. 2008, 46, 356.
  • 8Meragelman, T. L.; Tucker, K. D.; McClord, T. G.; Cardellina, J. H.; Shoemker, R. H. J. Nat. Prod. 2005, 68, 1790.
  • 9Hirpara, K. V.; Aggarwal, P.; Mukherjee, A. J.; Joshi, N.; Burman, A. C. Anticancer Agents Med. Chem. 2009, 9, 138.
  • 10Seshadri, T. R. Tetrahedron 1959, 6, 169.

共引文献25

同被引文献26

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部